Skip to main navigation Skip to search Skip to main content

Acute High Dose Melatonin for Encephalopathy of the Newborn (ACUMEN) Study: a protocol for a multicentre phase 1 safety trial of melatonin to augment therapeutic hypothermia for moderate/severe hypoxic ischaemic encephalopathy

  • ACUMEN Consortium
  • University College London
  • University College London Hospitals NHS Foundation Trust
  • KU Leuven
  • Royal Infirmary of Edinburgh
  • University of Edinburgh
  • Imperial College London
  • Royal College of Surgeons in Ireland
  • Monash University
  • Manchester University NHS Foundation Trust
  • Flinders University
  • Trinity College Dublin
  • Liverpool Women's NHS Foundation Trust
  • Queen Mary University of London
  • Leiden University

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Acute High Dose Melatonin for Encephalopathy of the Newborn (ACUMEN) Study: a protocol for a multicentre phase 1 safety trial of melatonin to augment therapeutic hypothermia for moderate/severe hypoxic ischaemic encephalopathy'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science